Effect of Hormone replacement therapy on breast cancer risk : Estrogen versus estrogen plus progestin

Hormone replacement therapy (HRT) given as unopposed estrogen replacement therapy (ERT) gained widespread popularity in the United States in the 1960s and 1970s. Recent prescribing practices have favored combination HRT (CHRT), i.e., adding a progestin to estrogen for the entire monthly cycle (conti...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JNCI : Journal of the National Cancer Institute 2000-02, Vol.92 (4), p.328-332
Hauptverfasser:	ROSS, R. K, PAGANINI-HILL, A, WAN, P. C, PIKE, M. C
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Biological and medical sciences Breast cancer Breast Neoplasms - chemically induced Breast Neoplasms - prevention & control California Case-Control Studies Estrogen Replacement Therapy - adverse effects Estrogens Estrogens - therapeutic use Female Gynecology. Andrology. Obstetrics Health risk assessment hormone replacement therapy Hormones Humans Mammary gland diseases Medical sciences Middle Aged Odds Ratio Progestins - therapeutic use Risk Risk Factors Time Factors Tumors USA, California
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!